Bayer trial combines two top drugs for kidney disease
Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
Digital health firm Omada prices $150m IPO
In another sign of recovery in digital health investing, Omada Health has priced an IPO that could value the company at more than $1.1 billion.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
15th World Clinical Biomarkers & Companion Diagnostics Summi...
The biomarkers and diagnostics field continues to boom, driven by advancements in genomic profiling, omics, and AI technologies.
5th iPSC Drug Development Summit
Advance iPSC therapies from bench to bedside with 30+ industry experts at this year’s summit.
Axtria Ignite 2025: Leading in an Agentic Era
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This
Register Now for AAPS PharmSci 360!
Learn from pharmaceutical scientists involved at every stage of the drug development pipeline at PharmSci 360.
4th Annual Process Development for Cell Therapies Summit
Driving Process Robustness, Scalability, Speed & Affordability